AI, Oppenheimer
Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...
Oppenheimer analyst Jay Olson downgraded Sutro Biopharma (STRO) to Perform from Outperform after the company reported Q4 results and announced ...
Ferguson (NASDAQ:FERG – Free Report) had its price target reduced by Oppenheimer from $234.00 to $189.00 in a report published on Wednesday morning,Benzinga reports. Oppenheimer currently has an ...
Shares of Roblox (NYSE:RBLX) are higher on Wednesday as the online gaming platform gears up for its highly anticipated "The ...
Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.
Adobe (NASDAQ:ADBE – Get Free Report) had its price target reduced by equities research analysts at Oppenheimer from $560.00 ...
Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...
Oppenheimer reiterates a Perform rating on Cartesian Therapeutics (RNAC) without a price target following the company’s Q4 report. The ...
Oppenheimer will be released on Netflix on March 21, 2025. The movie will be made available to stream on OTT platform with a ...
Showtime has cast David Dastmalchian ( Oppenheimer) in Dexter: Resurrection in the guest starring role of “Gareth.” ...
In a report released today, Brian Schwartz from Oppenheimer maintained a Hold rating on Sprinklr (CXM – Research Report). The company’s shares ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results